Rockefeller Capital Management
ATYR

Rockefeller Capital Management’s aTyr Pharma ATYR Stock Holding History

Rockefeller Capital Management’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.8K Hold
28,118
– – ﹤0.01% 3799
2026
Q1 		$21.9K Hold
28,118
– – ﹤0.01% 3677
2025
Q4 		$22K Hold
28,118
– – ﹤0.01% 3471
2025
Q3 		$20.3K Buy
+28,118
New +$127K ﹤0.01% 3340

Other funds holding ATYR

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Rockefeller Capital Management's ATYR Position: Q2 2026 in Review

Rockefeller Capital Management held its aTyr Pharma (ATYR) position steady in Q2 2026 at 28,118 shares worth $16.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3799.

Rockefeller Capital Management first reported a position in ATYR in Q3 2025 and has held it in 4 quarters since. The position peaked at $22K in Q4 2025. 90 funds tracked by Wall St. Rank hold ATYR as of Q2 2026.

  • Rockefeller Capital Management held 28,118 shares of aTyr Pharma worth $16.8K as of Q2 2026.
  • Rockefeller Capital Management left its aTyr Pharma share count unchanged in Q2 2026.
  • aTyr Pharma made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #3799 holding.
  • Rockefeller Capital Management first reported a position in aTyr Pharma in Q3 2025 and has held it in 4 quarters since.
  • Rockefeller Capital Management's aTyr Pharma position peaked at $22K in Q4 2025.
  • 90 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.